Cargando…

Leukaemia inhibitory factor is associated with treatment resistance in oesophageal adenocarcinoma

Oesophageal cancer is an aggressive disease with a poor 5 year survival rate of <20% of diagnosed patients. Unfortunately, only 20-30% Oesophageal Adenocarinoma (OAC) patients show a beneficial response to neoadjuvant therapy (neoCT). Inflammation influences OAC given the increased risk of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buckley, Amy M., Lynam-Lennon, Niamh, Kennedy, Susan A., Dunne, Margaret R., Aird, John J., Foley, Emma K., Clarke, Niamh, Ravi, Narayanasamy, O’Toole, Dermot, Reynolds, John V., Kennedy, Breandán N., O’Sullivan, Jacintha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6154751/ https://www.ncbi.nlm.nih.gov/pubmed/30263091 http://dx.doi.org/10.18632/oncotarget.25950

Ejemplares similares

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib
por: Buckley, Amy M., et al.
Publicado: (2020)

Altered Mitochondrial Function and Energy Metabolism Is Associated with a Radioresistant Phenotype in Oesophageal Adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
por: Davern, Maria, et al.
Publicado: (2021)

Impact of radiotherapy on the immune landscape in oesophageal adenocarcinoma
por: Donlon, Noel E, et al.
Publicado: (2022)

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells
por: Buckley, Amy M., et al.
Publicado: (2019)

The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation
por: Morrissey, Maria E., et al.
Publicado: (2020)

Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma
por: Mongan, Ann Marie, et al.
Publicado: (2019)

Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma
por: Melo, Ashanty M., et al.
Publicado: (2019)

The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus
por: Phelan, James J., et al.
Publicado: (2018)

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
por: Heeran, Aisling B., et al.
Publicado: (2021)

Energy Metabolism Is Altered in Radioresistant Rectal Cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

The Protein Secretome Is Altered in Rectal Cancer Tissue Compared to Normal Rectal Tissue, and Alterations in the Secretome Induce Enhanced Innate Immune Responses
por: Heeran, Aisling B., et al.
Publicado: (2021)

Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett’s Esophagus Compared to Esophageal Adenocarcinoma
por: O’Farrell, Naoimh J., et al.
Publicado: (2019)

PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma
por: Davern, Maria, et al.
Publicado: (2022)

The Role of Mitochondria in Optic Atrophy With Autosomal Inheritance
por: Strachan, Elin L., et al.
Publicado: (2021)

Radiation-induced Bystander Effect (RIBE) alters mitochondrial metabolism using a human rectal cancer ex vivo explant model
por: Heeran, Aisling B., et al.
Publicado: (2020)

Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer
por: Donlon, Noel E, et al.
Publicado: (2023)

Excess visceral adiposity induces alterations in mitochondrial function and energy metabolism in esophageal adenocarcinoma
por: Lynam-Lennon, Niamh, et al.
Publicado: (2014)

Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference
por: Kennedy, Sean P., et al.
Publicado: (2022)

1,4-dihydroxy quininib attenuates growth of colorectal cancer cells and xenografts and regulates the TIE-2 signaling pathway in patient tumours
por: Butler, Clare T., et al.
Publicado: (2019)

The Prognostic Value of the Lymph Node in Oesophageal Adenocarcinoma; Incorporating Clinicopathological and Immunological Profiling
por: Donlon, Noel E., et al.
Publicado: (2021)

Complement in Tumourigenesis and the Response to Cancer Therapy
por: O’Brien, Rebecca M., et al.
Publicado: (2021)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors
por: Kennedy, Susan A., et al.
Publicado: (2020)

Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers
por: Alhusaini, Abdullah, et al.
Publicado: (2021)

Evaluation of Cysteinyl Leukotriene Signaling as a Therapeutic Target for Colorectal Cancer
por: Burke, Lorraine, et al.
Publicado: (2016)

Thinking inside the box: intracellular roles for complement system proteins come into focus
por: O’Brien, Rebecca M., et al.
Publicado: (2023)

Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue
por: Cannon, Aoife, et al.
Publicado: (2020)

Home enteral nutrition recipients: patient perspectives on training, complications and satisfaction
por: Boland, Karen, et al.
Publicado: (2017)

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines
por: Donlon, Noel E., et al.
Publicado: (2020)

PD-1 and TIGIT blockade differentially affect tumour cell survival under hypoxia and glucose deprived conditions in oesophageal adenocarcinoma; implications for overcoming resistance to PD-1 blockade in hypoxic tumours
por: Davern, Maria, et al.
Publicado: (2022)

Energy Metabolism, Metabolite, and Inflammatory Profiles in Human Ex Vivo Adipose Tissue Are Influenced by Obesity Status, Metabolic Dysfunction, and Treatment Regimes in Patients with Oesophageal Adenocarcinoma
por: O’Connell, Fiona, et al.
Publicado: (2023)

HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients
por: Dunne, Margaret R., et al.
Publicado: (2017)

Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence
por: O’Farrell, N. J., et al.
Publicado: (2016)

Preclinical validation of the small molecule drug quininib as a novel therapeutic for colorectal cancer
por: Murphy, Adrian G., et al.
Publicado: (2016)

Rectal neuroendocrine tumours and the role of emerging endoscopic techniques
por: Keating, Eoin, et al.
Publicado: (2023)

Identification of TLR2 Signalling Mechanisms Which Contribute to Barrett’s and Oesophageal Adenocarcinoma Disease Progression
por: Flis, Ewelina, et al.
Publicado: (2021)

Curcumin induces apoptosis-independent death in oesophageal cancer cells
por: O'Sullivan-Coyne, G, et al.
Publicado: (2009)

Advances in Precision Medicine: Tailoring Individualized Therapies
por: Matchett, Kyle B., et al.
Publicado: (2017)

Can the Efficacy of [(18)F]FDG-PET/CT in Clinical Oncology Be Enhanced by Screening Biomolecular Profiles?
por: O’Neill, Hazel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mevrpdfnkv7rce3umtklah91au